Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave.
Yumeko KawanoNaomi J PatelXiaosong WangClaire E CookKathleen Mm VanniEmily N KowalskiEmily P BanasiakGrace QianMichael DiIorioTiffany Y-T HsuMichael E WeinblattDerrick J ToddZachary S WallaceJeffrey A SparksPublished in: Annals of the rheumatic diseases (2022)
The proportion of patients with SARD with severe COVID-19 has diminished since early in the pandemic, particularly during the most recent time periods, including the initial Omicron wave. Advances in prevention, diagnosis and treatment of COVID-19 may have improved outcomes among patients with SARD.